Changes in Lung Physiology & Cardiac Performance in Patients With

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05825261` - Exploring Novel Biomarkers for Emphysema Detection
Completed	`NCT02914340` - REACH SVS Control Patient Cross-Over Study	N/A
Completed	`NCT02999685` - Home-based Health Management of Chronic Obstructive Lung Disease (COPD) Patients	N/A
Completed	`NCT02238327` - Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes
Completed	`NCT02232841` - Electrical Impedance Imaging of Patients on Mechanical Ventilation	N/A
Withdrawn	`NCT01908933` - Study of the AeriSeal System Treatment in Patients With Advanced Non-Upper Lobe Predominant Heterogeneous Emphysema	Phase 3
Completed	`NCT01615484` - Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability	N/A
Completed	`NCT01476995` - Prognostic Indicators as Provided by the EPIC ClearView	N/A
Completed	`NCT01710449` - Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen	Phase 1
Suspended	`NCT00523094` - Vibration Response Imaging (VRI) in Patients That Are Candidates for Undergoing Pulmonary Operation Procedure	N/A
Completed	`NCT00475007` - Clinical Trial to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Treatment of Severe Emphysema	N/A
Recruiting	`NCT00129350` - Assessment of Heart and Heart-Lung Transplant Patient Outcomes Following Pulmonary Rehabilitation	Phase 1
Completed	`NCT01953523` - Safety and Clinical Outcomes Study: SVF Deployment for Orthopedic, Neurologic, Urologic, and Cardio-pulmonary Conditions	N/A
Completed	`NCT00000621` - Feasibility of Retinoic Acid Treatment in Emphysema (FORTE)	Phase 2
Completed	`NCT00005292` - Alpha1-antitrypsin Deficiency Registry	N/A
Recruiting	`NCT04537182` - Surgical Compared to Bronchoscopic Lung Volume Reduction in Patients With Severe Emphysema	N/A
Active, not recruiting	`NCT02713347` - Advancing Symptom Alleviation With Palliative Treatment	N/A
Recruiting	`NCT04302272` - STRIVE Post-Market Registry Study
Completed	`NCT04435327` - Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)
Completed	`NCT03636347` - A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo.	Phase 2

NCT number	NCT02499380
Study type	Observational
Source	Boston Scientific Corporation
Contact
Status	Terminated
Phase
Start date	June 9, 2015
Completion date	October 20, 2018

Changes in Lung Physiology and Cardiac Performance in Patients With Emphysema Post Bilateral RePneu Coil Treatment

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms